Healthcare Cost News: 5 Headlines to Know (Aug 2026)

What Healthcare Cost News Should You Watch in August 2026?

Healthcare cost news this August delivered a one-two punch: a new cancer drug priced near $30,000 per cycle and a looming Medicare rule that could slash billions in out-of-pocket spending. From Aug 10–24, 2026, five headlines shaped what U.S. consumers will pay next — here’s the breakdown.

How This Was Verified

All figures trace to primary documents, including FDA notices, CMS fact sheets, Aon projections, and Commonwealth Fund reports, each linked inline. Prices and dates were verified on Aug 24, 2026. No clinical advice is offered — this is a cost-focused summary. HealthyWallet follows strict editorial standards for accuracy and transparency.

FDA Approves Zenbexus — What Does a $29,500/Cycle Cancer Drug Cost You?

Zenbexus (iberdomide) won accelerated approval on Aug 13, 2026, for relapsed/refractory multiple myeloma Source. Bristol-Myers Squibb set the list price at $29,500 per 28-day cycle — a derived annual cost of ~$354,000 ($29,500 × 12) Source. Distribution is REMS-restricted, limiting pharmacy access Source. Roughly 36,000 new myeloma cases are expected in 2026 Source. Medicare patients taking an oral oncology drug such as Zenbexus are protected by the Part D $2,000 out-of-pocket cap on covered prescription costs Source.

Employer Health Costs Projected to Top $19,000 per Employee in 2027

Aon projects employer health costs will rise 9.5% in 2027, pushing average spending above $19,000 per employee Source. In 2026, total plan cost hit $17,562 (+8.3%), with employee premium contributions rising 6.4% to $3,130 and out-of-pocket costs climbing 10.2% to $2,167 Source. Total employee cost averaged $5,297 (+7.9%). GLP-1 and specialty drugs are key cost drivers. The trend echoes the individual market, where ACA marketplace premiums face a median proposed increase of 14% for 2027 — see our ACA marketplace premium analysis for the breakdown.

New Alzheimer’s Blood Test Clears FDA — But What Will It Cost?

On Aug 24, 2026, the FDA cleared Elecsys pTau217, a blood test that detects Alzheimer’s-related changes in adults 55+ with cognitive decline Source. The test runs on 4,500+ existing Roche analyzers, and Labcorp and Quest plan to offer it. However, no price has been disclosed as of Aug 24, 2026 — so any dollar estimate is speculative. If priced competitively, it could reduce costs versus PET scans or spinal taps.

CMS Proposes Billions in Medicare Savings — Here’s What Beneficiaries Could Gain

CMS’s CY 2027 OPPS/ASC proposed rule (CMS-1850-P) includes site-neutral imaging pay and a 340B drug-payment cut Source. If finalized, beneficiaries could save ~$70 million in year-one imaging cost-sharing and ~$1.15 billion in year-one drug payments Source. The public comment deadline is Aug 31, 2026, at 11:59 PM EDT Source. This is a proposal only — final rule expected ~Nov 2026, effective Jan 1, 2027 if finalized.

State Medical-Debt Protections: Where the Gaps Leave Patients Exposed

A Commonwealth Fund report dated Aug 6, 2026 (covered Aug 20) found 3 in 10 U.S. adults are affected by medical debt Source. While 14 states bar medical debt from credit reports and 23 bar wage garnishment, gaps remain: 21 states set financial-assistance standards, but 5 of those limit aid to the uninsured Source. Only 8 states require pre-collection assistance screening, and 19 collect no charity-care data.

What Can You Do Right Now?

• Submit a public comment on CMS-1850-P by Aug 31, 2026, at regulations.gov.
• Check your state’s medical-debt protections using the Commonwealth Fund report.
• Review your employer plan’s out-of-pocket trend before open enrollment — see our how to hedge rising healthcare costs guide.
• If you’re on Medicare and take oral oncology drugs, verify your Part D $2,000 out-of-pocket cap applies — start with our health finance tools.
• Use health finance tools to estimate your 2027 costs under rising employer premiums.
• If you buy your own coverage, open enrollment runs Nov 1, 2026 through Jan 15, 2027 — compare total costs before premiums reset with our guide to choosing a health insurance plan.
• If you take a specialty drug, review your plan’s 2027 formulary when it’s released this fall — a tier or coverage change can shift your out-of-pocket costs by thousands, and the CMS proposed rule targets drug-payment reductions that could ease that burden if finalized.

FAQ

Will the CMS proposed rule lower my Medicare costs in 2027?

If finalized, yes — but only starting Jan 1, 2027. The proposed rule would reduce imaging cost-sharing by ~$70 million and drug payments by ~$1.15 billion in year one Source. Since it’s still a proposal, no savings are guaranteed until the final rule is published.

How much will the new Alzheimer’s blood test cost?

As of Aug 24, 2026, no price has been disclosed Source. Labcorp and Quest will offer it, but cash and insurance prices remain unknown. Watch for future announcements on coverage and pricing.

What states protect patients from medical debt on credit reports?

Fourteen states fully bar medical debt from credit reports Source. Consumers in all other states should monitor their credit and dispute any medical debt entries.